66 studies found for:    SDF
Show Display Options
Rank Status Study
1 Unknown  The Effect of Three Different Fluids(Albumin 5%, Normal Saline, Hydroxyethyl Starch 130 kD) on Microcirculation in Severe Sepsis/Septic Shock Patients
Conditions: Severe Sepsis;   Septic Shock;   Microcirculation
Interventions: Device: Sidestream Dark Field (SDF);   Device: Near Infrared Spectroscopy (NIRS)
2 Completed Perioperative Observation of the Sublingual Microcirculation With SDF
Condition: Surgery
Intervention:
3 Completed Microcirculatory Perfusion in Patients With Coma After Out-of-hospital Cardiac Arrest
Condition: Cardiac Arrest
Intervention: Device: microcirculation by SDF and NIRS, in 33 and 36 degrees
4 Unknown  Functional Improvement of Progenitor Cells and Endothelial Function by Vildagliptin in Diabetes Mellitus (FINNjA-DM).
Condition: SDF-1 is an Important Cytokine for Neovascularization. Cleavage of SDF-1 is Reduced by DPPIV Inhibitors
Intervention: Drug: Vildagliptin
5 Not yet recruiting Effectiveness of Dental Caries Arrest Treatment in Primary Teeth Using AgNO3 Followed by NaF Varnish
Condition: Early Childhood Caries
Interventions: Drug: 25% AgNO3 solution followed by 5% NaF varnish;   Drug: 38% SDF solution followed by placebo varnish
6 Unknown  The Role of SDF-1/CXCR4 in Metastasis of Oral Squamous Cell Carcinoma
Condition: Oral Cancer
Intervention:
7 Unknown  The Role of Stromal Cell-Derived Factor-1 (SDF-1)/CXC Chemokine Receptor 4 (CXCR4) in Metastasis of Laryngeal and Hypopharyngeal Squamous Cell Carcinoma
Conditions: Laryngeal Cancer;   Hypopharyngeal Cancer;   Metastasis
Intervention:
8 Completed Prevalence of Microcirculatory Alterations in Intensive Care Patients
Condition: Critical Illness
Intervention:
9 Completed The Effect of Nitroglycerine on Microcirculatory Abnormalities During Sepsis
Conditions: Sepsis;   Septic Shock
Interventions: Drug: nitroglycerin iv;   Drug: placebo = nacl 0.9%
10 Completed The Effect of Ketanserin on the Microcirculation in Sepsis
Conditions: Severe Sepsis;   Septic Shock
Intervention: Drug: ketanserin
11 Active, not recruiting Sidestream Dark-Field (SDF) Imaging of the Intestinal Microcirculation
Condition: Sepsis
Intervention:
12 Completed Microcirculation in Continuous Venovenous Hemofiltration Patients on the Intensive Care Unit
Condition: Continuous Venovenous Hemofiltration
Intervention:
13 Recruiting Diabetic Macular Edema Treated With Ozurdex (DMEO)
Condition: Diabetic Macular Edema
Intervention: Drug: OZURDEX
14 Active, not recruiting Chemosensitization With Plerixafor Plus G-CSF in Acute Myeloid Leukemia
Condition: Leukemia, Myeloid, Acute
Interventions: Drug: G-CSF;   Drug: Plerixafor;   Drug: Mitoxantrone;   Drug: Etoposide;   Drug: Cytarabine
15 Active, not recruiting NOX-A12 in Combination With Bortezomib and Dexamethasone in Relapsed Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: NOX-A12
16 Completed Effect of Sitagliptin on Endothelial Progenitor Cells
Condition: Type 2 Diabetes Mellitus
Intervention: Drug: Sitagliptin
17 Completed
Has Results
Dipeptidyl Peptidase-4 Inhibition and Immune Function in HIV
Conditions: Diabetes;   Insulin Resistance
Interventions: Drug: Sitagliptin;   Drug: Placebo
18 Completed
Has Results
Hemodynamic and Perfusion Response to Drotrecogin Alfa (Activated) in Patients With Septic Shock
Conditions: Sepsis;   Septic Shock
Intervention: Drug: drotrecogin alfa (activated)
19 Active, not recruiting
Has Results
Erlotinib and Radiation Therapy in Treating Young Patients With Newly Diagnosed Glioma
Condition: Brain and Central Nervous System Tumors
Intervention: Drug: Erlotinib hydrochloride
20 Recruiting Pilot Study of Lymphoid Tumor Microenvironmental Dysruption Prior to Autologous Stem Cell Transplantation
Conditions: Chronic Lymphocytic Leukemia;   Lymphoma;   Multiple Myeloma
Intervention: Drug: Plerixafor

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years